Literature DB >> 30873675

Acute effect of an amino acid mixture in the rat glycemic profile.

Maria J Pena1,2,3, Susana G Guerreiro2,4,5,6, Júlio C Rocha1,7,8,9, Tiago Morais3, Sofia S Pereira4,5,3, Mariana P Monteiro3, Nuno Borges6,9.   

Abstract

Amino acid mixtures (AAM) are protein substitutes used for phenylketonuria treatment, but their metabolic effects have not been well characterized. The objective of this study was to compare the acute glycemic response to free amino acids (free AA) from AAM with the response to intact protein (iProtein). Male Wistar rats (n = 14) were administered by gavage a bolus of free AA (n = 7) or iProtein as albumin (n = 7) containing equivalent amounts of nitrogen. Blood glucose and insulin levels were measured at baseline and 15, 30, 60 and 120 minutes later, when gut GLP-1 content and pancreatic insulin, GLP-1 receptor and Ki67 expression were quantified at 120 minutes time point. After AAM, glucose area under the curve (free AA vs iProtein; P < 0.01), serum insulin levels at 120 minutes (free AA vs iProtein; P < 0.05), colon GLP-1 content (free AA vs iProtein; P < 0.01), pancreatic GLP-1 receptor (free AA vs iProtein; P < 0.01) and insulin expression (free AA vs iProtein; p < 0.01) were significantly lower as compared with iProtein. AAM increased Ki67 expression in pancreatic islets (free AA vs iProtein; P < 0.05). In conclusion, this study demonstrated that acute response to AAM differs from iProtein and is characterized by a lower glucose excursion, along with a decrease in gut GLP-1 and pancreatic GLP-1 receptor and insulin. This data suggests the modulation of glycemia by free AA is mediated by the incretin axis.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  GLP-1; amino acids; glucose; insulin; phenylketonuria

Year:  2019        PMID: 30873675     DOI: 10.1002/jcb.28576

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  2 in total

1.  Continuous use of glycomacropeptide in the nutritional management of patients with phenylketonuria: a clinical perspective.

Authors:  Maria João Pena; Alex Pinto; Manuela Ferreira de Almeida; Catarina de Sousa Barbosa; Paula Cristina Ramos; Sara Rocha; Arlindo Guimas; Rosa Ribeiro; Esmeralda Martins; Anabela Bandeira; Cláudia Camila Dias; Anita MacDonald; Nuno Borges; Júlio César Rocha
Journal:  Orphanet J Rare Dis       Date:  2021-02-13       Impact factor: 4.123

2.  In Vivo Metabolic Responses to Different Formulations of Amino Acid Mixtures for the Treatment of Phenylketonuria (PKU).

Authors:  Nadia Giarratana; Luciana Giardino; Andrea Bighinati; Giorgio Reiner; Júlio César Rocha
Journal:  Int J Mol Sci       Date:  2022-02-17       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.